Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesogaberan in refractory chronic cough
ISRCTN77000698Phase 2Completed
- Sponsor
- Wythenshawe Hospital
- Start
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of lesogaberan in refractory chronic cough (RCC) (2 arms), sponsored by Wythenshawe Hospital. Primary endpoint: 24-hour objective cough frequency following 2 weeks treatment. Started Apr 2015; status: completed.
02
Drugs
lesogaberan
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on ISRCTN77000698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN77000698.